Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Clinical trial NCT07388524 · RECRUITING

Trial details

NCT number: NCT07388524
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Non-Small Cell Carcinoma

Start date: 2027-03-02
Primary completion: 2032-09-30
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.